Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy

AIMS: Immunoadsorption with subsequent immunoglobulin G substitution (IA/IgG) represents a novel therapeutic approach in the treatment of dilated cardiomyopathy (DCM) which leads to the improvement of left ventricular ejection fraction (LVEF). However, response to this therapeutic intervention shows...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameling, Sabine, Herda, Lars R., Hammer, Elke, Steil, Leif, Teumer, Alexander, Trimpert, Christiane, Dörr, Marcus, Kroemer, Heyo K., Klingel, Karin, Kandolf, Reinhard, Völker, Uwe, Felix, Stephan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584995/
https://www.ncbi.nlm.nih.gov/pubmed/23100283
http://dx.doi.org/10.1093/eurheartj/ehs330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584995/
https://www.ncbi.nlm.nih.gov/pubmed/23100283
http://dx.doi.org/10.1093/eurheartj/ehs330

Ejemplares similares